![]() ![]() We hope to promote the practical application of medical AI. Sogou CEO Wang Xiaochuan stated, "We are very happy to be two round investors of AirDoc. AirDoc’s highly accurate chronic disease screening technology combined with Fosun's products, services and healthcare systems will be an efficient enabler of artificial intelligence and effectively contribute to the healthy China strategy." The additional investment will also enable AirDoc to conduct comprehensive collaboration with hospitals, insurance companies, pharmaceutical companies, and health management companies to accelerate medical AI technology.Īccording to Chen Qiyu, executive director and co-president of Fosun International, "Fosun attaches great importance to the organic integration of new technologies and business, and also actively invests in new technologies with potential in independent research and development. After this round of financing is completed, AirDoc will bring to market a wide range of application scenarios and business models based on its current successful pilots. In the past three years, AirDoc has conducted screening for chronic diseases in many provinces and cities throughout China including Beijing, Shanghai, Hainan, Jiangsu, Hebei, and Anhui, providing tens of thousands of people with rapid diagnosis suggestions every day. Our new close relationship with Fosun and Sogou will help jointly build a new era of comprehensive health with doctors and patients as the center." Every day, more than 100,000 doctors use AirDoc Ask to assist in their decision-making. The data labels of each sample were independently marked and cross-controlled by multiple skilled industry experts, thus ensuring the rigor of the data materials.ĪirDoc founder and CEO Zhang Dalei said, "AirDoc's AI medical image recognition technology has become an indispensable tool at hundreds of medical institutions in the United States and China. ![]() To ensure high quality, AirDoc has collected millions of medical images from the world's top medical institutions, including the top-ranking eye hospitals in China, to build multi-layer convolutional neural networks. In addition, AirDoc announced the launch of an online and offline integration of Fosun and Sogou's intelligent prevention and control system for chronic diseases.Īfter more than 3 years of development, the AirDoc team has built an artificial intelligence chronic disease recognition system, including a retina/fundus-based algorithm that can identify more than 30 chronic diseases, including systemic chronic disease complications such as diabetes, hypertension, arteriosclerosis, and optic nerve diseases, as well as glaucoma, age-related macular degeneration and other common eye diseases. Seattle, WA, Ap-( PR.com)- AirDoc, the leader in artificial intelligence for healthcare, announced that it has completed a Series B financing led by Fosun Investments and Sogou Investments, and the three parties will jointly explore a better integration of their product lines for medical artificial intelligence. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |